Integrated Chinese and Western medicine improves the quality of life in patients during the perioperative period of lung cancer: a multicenter, randomized, controlled clinical study

Not Applicable

Recruiting

• Conditions: lung cancer

• Registration Number: ITMCTR2100004649
• Lead Sponsor: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1.Patients with lung space occupying lesions removed by video-assisted thoracoscopic surgery and pathologically confirmed to be lung cancer;
2.Preoperative examination showed no absolute contraindications to surgery;
3.Patients have good compliance in the treatment, can understand the situation of this study and sign the informed consent.

Exclusion Criteria

1.Patients received total pneumonectomy, pulmonary arterioplasty or bronchial sleeve lobectomy;
2.The intraoperative blood loss was more than 1000 mL or video-assisted thoracoscopic surgery transferred to thoracotomy;
3.There were signs of active bleeding after surgery, which required thoracotomy for hemostasis;
4.Patients refuse to receive lung rehabilitation training;
5.The postoperative drainage time is more than 7 days;
6.Patients used double thoracic tube drainage after surgery or transferred to ICU.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of Life;

Secondary Outcome Measures

Name	Time	Method
symptom assessment;Evaluation of traditional Chinese medicine clinical syndromes;Physical Status Assessment;